---
title: "CNS Pharmaceuticals, Inc. (CNSP.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CNSP.US.md"
symbol: "CNSP.US"
name: "CNS Pharmaceuticals, Inc."
industry: "制药"
---

# CNS Pharmaceuticals, Inc. (CNSP.US)

| Item | Detail |
|------|--------|
| Industry | 制药 |
| Location | 美股市场 |
| Website | [www.cnspharma.com](https://www.cnspharma.com) |

## Company Profile

CNS Pharmaceuticals, Inc.是一家临床制药公司，开发用于治疗脑部和中枢神经系统（CNS）肿瘤的抗癌药物候选者。该公司的药物候选者包括 TPI 287 和 Berubicin，目前正在进行针对胶质母细胞瘤和其他中枢神经系统恶性肿瘤的第二阶段临床试验。公司与 Cortice Biosciences, Inc.签订了许可协议。该公司成立于 2017 年，总部位于德克萨斯州休斯顿

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.15 | 69/257 | - | - | - |
| PB | 0.20 | 9/257 | 0.51 | 0.40 | 0.33 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-10T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 1 | 100% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 3.25 |
| Highest Target | 20.00 |
| Lowest Target | 20.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/CNSP.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CNSP.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CNSP.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.